Company Overview
Snapshot
Founded in January 2023 by Vitalay Fomin and Amit Weiss, Numenos operates with 11–50 employees. The company has secured funding across one round from one investor. In January 2025, Numenos received seed funding from TechAviv Founder Partners.
Business overview
Numenos is a techbio company specializing in the development of a clinico-genomic foundation model. Operating within the Health Tech & Life Sciences sector, the company focuses on leveraging advanced technology to create foundational models for clinical and genomic data, serving the healthcare industry.
Log in to access full profile ›Company Intelligence Q&A
- When was Numenos founded and by whom?
- Numenos was founded in January 2023 by co-founders Vitalay Fomin and Amit Weiss.
- What is Numenos' primary focus?
- Numenos is a techbio company focused on developing a clinico-genomic foundation model.
- Which sector does Numenos primarily operate in?
- Numenos primarily operates in the Health Tech & Life Sciences sector.
- How many employees does Numenos have?
- Numenos currently has 11–50 employees.
- Has Numenos received any funding?
- In January 2025, Numenos received seed funding from TechAviv Founder Partners.